A Disappointment in Triple-Negative Breast Cancer ...Middle East

Medscape - News
The oral AKT inhibitor ipatasertib does not seem to offer any clinical benefit when added to paclitaxel for women with gene-altered advanced triple- negative breast cancer, indicate phase 3 trial data. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( A Disappointment in Triple-Negative Breast Cancer )

Apple Storegoogle play

Also on site :